Paragon 28, Inc. Profile Avatar - Palmy Investing

Paragon 28, Inc.

Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide,…

Medical - Devices
US, Englewood [HQ]

Risk Factors

By Management
10-K
  1. Our medical device products may cause or contribute to adverse medical events or be subject to failures or malfunctions that we are required to report to the FDA or foreign regulatory authorities, and if we fail to do so, we would be subject to sanctions that could harm our reputation, business, financial condition and results of operations. The discovery of serious safety issues with our products, or a recall of our products either voluntarily or at the direction of the FDA or another governmental authority, could have a negative impact on us.

  2. We have previously been party to lawsuits involving patents and other intellectual property and the possibility exists that we may in the future be party to other lawsuits or administrative proceedings involving patents or other intellectual property. If we were to lose any intellectual property lawsuits, a court could require us to pay significant damages and/or prevent us from selling our products.

  3. Our employees and independent contractors, including independent sales representatives and any other consultants, any future service providers and other vendors, may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could have an adverse effect on our results of operations.

Get PRO Today.

Read 22 more risk factors of Paragon 28, Inc.

End of FNA's Analysis
CIK: 1531978 CUSIP: 69913P105 ISIN: US69913P1057 LEI: - UEI: -
Secondary Listings
FNA has no secondary listings inside our databases.